Press Release
RainDance Dedicates New Headquarters, Manufacturing Facility
LEXINGTON, MASS. – Sept. 26, 2008 — RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, today dedicated its new headquarters and operations building and unveiled its new RDT 1000 instrument.
Keynoting the event was Sir Richard Roberts, 2003 Nobel Prize winner for physiology and medicine and Founder and Chief Scientific Officer of New England Biolabs. Chris McNary, President and Chief Executive Officer, RainDance Technologies; Daniel O’Connell, Secretary of Housing and Economic Development, Commonwealth of Massachusetts; and Robert Coughlin, President and Chief Executive Officer, Massachusetts Biotechnology Council, also spoke at the event.
“The development of new technology has driven the pace of discovery in health and human disease research,” said Sir Richard Roberts. “RainDance technology has the potential to accelerate breakthroughs in genomic research and fulfill the promise of personalized medicine.”
RainDance is among the first companies to relocate to Massachusetts under Governor Deval Patrick’s innovative Life Sciences Initiative. The company cited the initiative as a major factor in moving the company’s operations from Connecticut to Massachusetts.
“Today, our dream of bringing innovative products to market is becoming a reality here in Lexington, as we dedicate this new 28-thousand square foot facility,” said Chris McNary, president and chief executive officer, RainDance Technologies. “We liked what we saw in Massachusetts. Its access to life science talent, state research grants, and the customer base of the greater Boston-Cambridge area were important requirements for our growing company,” said McNary.
RainDance cited Secretary O’Connell, the Governor’s Office, and the Massachusetts Biotechnology Council for making the company’s relocation a smooth and seamless transition.
“Strong public-private partnerships have made Massachusetts a leader in life sciences and personalized medicine with a growing base of companies and research institutions,” said O’Connell. “RainDance will play an important role in continuing that leadership.”
“We are proud to have RainDance Technologies join the impressive list of life sciences companies basing their operations in Massachusetts,” said Coughlin. “Their innovative technology and unique knowledge will add vitality to our biotechnology community.”
During the ceremony, the company unveiled a rendering of the RDT 1000 instrument, the centerpiece of its new Sequence Enrichment solution for the targeted genomic sequencing market.
“Soon, we will be delivering our sequence enrichment solution to early access partners representing some of the nation’s leading genome centers,” said McNary. “This technology will be introduced to the market during the fourth quarter, with commercial launch scheduled for the first quarter of 2009.”
RainDance’s new RainStorm™ droplet-based microfluidic technology has broad use in the prediction and prevention of human disease. The simplicity, speed, and capacity of the technology will enable numerous uses in biomedical applications, including genomics research, gene expression analysis, compound screening, and biomarker detection.
About RainDance Technologies
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company's core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, precision and simplicity of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainDance, RainStorm, ThunderStorm, Digital Biology are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.
For technical questions contact:
James Brayer
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
781-861-6300
info@raindancetech.com
For press inquiries:
Colin Sanford
203-340-2441
colin@bioscribe.com
